Public Health Bulletin on HIV and STIs in the Grand Est region. December 2021.

Published on 13 December 2021

Key points

In 2020, due to the health crisis, participation in LaboVIH declined in the Grand-Est region as well as nationwide. Participation in the LaboVIH survey and the accurate reporting of new HIV diagnoses via e-DO by clinicians and laboratory professionals are essential for the production of reliable surveillance indicators.
Decrease in HIV testing in the Grand-Est region (serology tests and sales of HIV self-tests), particularly during the first lockdown.
The annual rate of new HIV diagnoses has remained stable since 2010 and is similar to that observed in metropolitan France excluding the Île-de-France region.
Decrease in the proportion of recent HIV infections, increase in HIV-positive diagnoses at an advanced stage, and increase in the proportion of infections among heterosexuals born in France in 2020 in the Grand-Est region.
A slight increase in the number of AIDS diagnoses, estimated at 12 per million inhabitants in 2020 in the Grand-Est region.
e-DO: increase in the proportion of reports covering both components in 2020, with an increase in the proportion of reports covering only the “clinician” component and a decrease in those covering only the “laboratory” component.

In 2020, regardless of the STI, a decline in the screening rate (for both men and women) was observed in the Grand-Est region as well as at the national level.
A decrease in the number of tests performed in private clinical laboratories for syphilis, gonorrhea, and Chlamydia trachomatis in 2020 in the Grand-Est region, mirroring the situation in France. The screening rate for these STIs remains higher among women.